Clinical Trial Update: Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 study evaluating TissueGene-C for osteoarthritis, highlighting efficacy and safety outcomes. The sponsor is Kolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• TissueGene-C (TG-C)

Snippet

Sponsor: Kolon Life Science | Conditions: Degenerative Arthritis | Phase 3 | Status: COMPLETED